Sunday, October 16, 2016

Diprobase Ointment





1. Name Of The Medicinal Product



Diprobase Ointment


2. Qualitative And Quantitative Composition



No pharmacologically active components



3. Pharmaceutical Form



Ointment



4. Clinical Particulars



4.1 Therapeutic Indications



Diprobase Ointment is an emollient, moisturising and protective ointment for the follow-up treatment with topical steroids or in spacing such treatment. It may also be used as diluent for topical steroids. Diprobase Ointment is recommended for the symptomatic treatment of red inflamed, damaged, dry or chapped skin, the protection of raw skin areas and as a pre-bathing emollient for dry/eczematous skin to alleviate drying areas.



4.2 Posology And Method Of Administration



Adults and Children :



The ointment should be thinly applied to cover the affected area completely, massaging gently and thoroughly into the skin. Frequency of application should be established by the physician. Generally, Diprobase Ointment can be used as often as required.



4.3 Contraindications



Hypersensitivity to any of the components of the ointment is a contraindication to its use.



4.4 Special Warnings And Precautions For Use



None stated.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None stated.



4.6 Pregnancy And Lactation



None stated.



4.7 Effects On Ability To Drive And Use Machines



None stated.



4.8 Undesirable Effects



Skin reactions including pruritus, rash, erythema, skin exfoliation, burning sensation, hypersensitivity, pain, dry skin and bullous dermatitis have been reported with product use.



4.9 Overdose



None stated.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Diprobase Ointment contains no active ingredients and has no pharmacological action. The ingredients have an emollient action on dry or chapped skin.



5.2 Pharmacokinetic Properties



Not applicable due to topical administration and direct action on the skin.



5.3 Preclinical Safety Data



There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SmPC.



6. Pharmaceutical Particulars



6.1 List Of Excipients



White soft paraffin



Liquid paraffin.



6.2 Incompatibilities



None known.



6.3 Shelf Life



60 months (tube presentations)



36 months (500gm plastic jar with screw cap)



6.4 Special Precautions For Storage



Store below 25°C.



6.5 Nature And Contents Of Container



5, 50 and 100gm: Epoxy lined aluminium tubes with plastic caps.



500gm: White polypropylene jar closed with a white tamper-evident low density polyethylene screw cap.



6.6 Special Precautions For Disposal And Other Handling



Not applicable.



7. Marketing Authorisation Holder



Merck Sharp & Dohme Limited



Hertford Road



Hoddesdon



Hertfordshire



EN11 9BU, UK



8. Marketing Authorisation Number(S)



PL 00025/0574



9. Date Of First Authorisation/Renewal Of The Authorisation



12 April 1996/ 29 January 2007



10. Date Of Revision Of The Text



28 March 2011



11 LEGAL CATEGORY


GSL



© Merck Sharp & Dohme Limited 2011. All rights reserved.



DIPOIN/UK/03-11/7





No comments:

Post a Comment